Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome-Reference-Cited by-同舟云学术

Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome

Published:2023-08 Issue: Volume:94 Page:104711
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Díez-Cirarda Maria^ORCID,Yus-Fuertes Miguel,Sanchez-Sanchez Rafael,Gonzalez-Rosa Javier J.,Gonzalez-Escamilla Gabriel,Gil-Martínez Lidia,Delgado-Alonso Cristina,Gil-Moreno Maria Jose,Valles-Salgado Maria,Cano-Cano Fatima,Ojeda-Hernandez Denise,Gomez-Ruiz Natividad,Oliver-Mas Silvia,Benito-Martín María Soledad,Jorquera Manuela,de la Fuente Sarah,Polidura Carmen,Selma-Calvo Belén,Arrazola Juan,Matias-Guiu Jorge,Gomez-Pinedo Ulises^ORCID,Matias-Guiu Jordi A.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference77 articles.

1. A clinical case definition of post-COVID-19 condition by a Delphi consensus;Soriano;Lancet Infect Dis,2022

2. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis;Premraj;J Neurol Sci,2022

3. Fatigue and cognitive dysfunction are associated with occupational status in post-COVID syndrome;Delgado-Alonso;Int J Environ Res Public Health,2022

4. Neuropsychological deficits in patients with cognitive complaints after COVID-19;García-Sánchez;Brain Behav,2022

5. Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints;Ariza;Front Aging Neurosci,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seeing through the fog: a neuroendocrine explanation for post-COVID cognitive deficits;Nature Reviews Endocrinology;2024-01-29

2. Neuropathological findings in COVID-19 vs. non-COVID-19 acute respiratory distress syndrome—A case-control study;Frontiers in Neurology;2023-12-22

3. Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities;Biomolecules;2023-12-20

4. Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are Unsuitable for Assessing Post-COVID Cognitive Impairment;The Journal of Infectious Diseases;2023-11-30

5. Effects of COVID-19 on cognition and brain health;Trends in Cognitive Sciences;2023-11